Effectiveness and Safety of Guilu Erxian Oral Liquid in the Treatment of Oligozoospermia and Asthenospermia With Syndrome of Shen (Kidney) Essence Deficiency

Clinical trial NCT07270146 · COMPLETED

Trial details

NCT number: NCT07270146
Sponsor: DongE E Jiao Coporation Limited
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Mild and Moderate Oligozoospermia Asthenospermia or Oligoasthenospermia and the Syndrome Differentiation Type is Shen (Kidney) Essence Deficiency

Start date: 2022-10-08
Primary completion: 2025-02-10
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.